Navigation Links
New Moffitt Cancer Center patent promises to accelerate cancer trials
Date:2/14/2012

TAMPA, Fla. A new patent has been issued to Moffitt Cancer Center for a computerized system that efficiently selects the right patient for the right clinical trial. The newly patented system matches the registered patient's own molecular profile warehoused in a database of thousands of patient-donated biological tissue or tumor samples to the molecular design of the drug aimed at targeting their disease at the molecular level, and does it quickly. The system promises to accelerate clinical trials and help shorten the time that it takes to get critically needed new drugs into the market.

Getting new drugs to market to fight cancer and other serious diseases requires, on average, 15 years. The drug development process is long and complex, but the three-phase clinical trials process estimated to take up to half of those 15 years is often the bottleneck in getting innovative drugs to the patients who need them.

Clinical trials, increasingly becoming more expensive, are also multifaceted. While patients may qualify for a clinical trial based on their age or stage of disease, they may not be, over the long term of the trial, the best candidates to test a drug. Adverse events, changes in a patient's health status and the potential for a drug not being effective for them slow the process. Although patients may have met the trial protocol's criteria, the drug may not be right for them because their molecular profile is not a good match for the chemical and molecular properties of the drug.

Because the concept of personalized medicine is selecting the right drug for the right patient, innovations have been needed to bring personalized medicine to reality. Personalizing the selection process for clinical trials is a vital step.

With the development of new and better ways to examine and understand a tumor's molecular profile, matching the right patient to the right clinical trial becomes increasingly important. But handling the massive data evaluation necessary to accomplish this has been a stumbling block.

The newly patented computer system, Patent Number US 8,095,389 B2, or "Computer Systems and Methods for Selecting Patients for Clinical Trials," is designed to surmount that problem.

The newly patented computer system is designed to:

  • Select patients to clinical trials matching an individual's/drug's molecular profile
  • Match patients to clinical trials by a patient's disease/diagnosis
  • Match patients to clinical trials by their symptoms
  • Match patients to clinical trials by their demographic information and family history
  • Track a clinical trial participant's disease progression compared to drug efficacy

The newly patented computer system and associated products, such as operating system, software, interfaces and data retrieval system, improve clinical trial selection efficacy by making the patient selection process less random and more selective. The technology has the potential to refine clinical trials by eliminating bottlenecks, overhauling the selection process and shortening the timeline, ultimately bringing new drugs to market more efficiently.


'/>"/>
Contact: Michelle Foley
Michelle.Foley@moffitt.org
813-745-1505
H. Lee Moffitt Cancer Center & Research Institute
Source:Eurekalert

Related medicine news :

1. Moffitt, Sanford-Burnham and Florida Hospital create Personalized Medicine Partnership of Florida
2. Fibroblasts contribute to melanoma tumor growth, say Moffitt Cancer Center researchers
3. Moffitt Cancer Center researchers find potential target for treating metastatic cancer
4. Moffitt researchers will be strong participants in American Society of Hematology meeting
5. Moffitt Cancer Center researchers find MK1775 active against sarcomas
6. Moffitt Cancer Center researchers find men less willing to be screened for cancer
7. Moffitt Cancer Center researchers unravel biochemical factor important in tumor metastasis
8. Moffitt Cancer Center researchers find regulatory T-cell clue to help prevent GVHD
9. Moffitt Cancer Center researchers find more clues to causes of breast cancer
10. Moffitt researchers find possible key to preventing chemotherapy resistance in ovarian cancer
11. Moffitt Cancer Center researchers use new tool to counter multiple myeloma drug resistance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... February 10, 2016 , ... ... Jacksonville, FL 32224, February 26th: Amateur & Professional Divisions - Time: 7:00pm ... 7:00pm – 10:00pm | Ticket Prices $30, Social Media: http://www.USPoleSportsFed.org , ...
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... Workrite Ergonomics, ... company that has evolved from humble beginnings to being an internationally recognized leader in ... that we are today”, said Charlie Lawrence, President of Workrite. “Workrite recognized the ...
(Date:2/10/2016)... ... 2016 , ... Anxiety of older Americans over steep cost increases of prescription ... decade ago, according to The Senior Citizens League (TSCL). Since last ... with rapidly rising costs. “The implications are chilling, particularly for people with chronic ...
(Date:2/10/2016)... Puente, California (PRWEB) , ... February 09, 2016 ... ... Medicine students, faculty and staff helped give free oral screenings to 150 children ... Feb. 5, 2016. , The College of Dental Medicine joined Chinese American Dental ...
(Date:2/10/2016)... Angeles, CA (PRWEB) , ... February 09, 2016 , ... ... surgeons are witnessing a dramatic increase in the number of patients under the age ... reflects what they are seeing in their offices, and may indicate an overall shift ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... ALSP, Inc. announced that it has appointed Col.(Retired) ... Affairs in preparation for its move into clinical trials with ... stated, "We are pleased to welcome Dallas Hack ... an individual of such practical knowledge and far-reaching experience in ... on his broad experience and success as a clinician and ...
(Date:2/10/2016)... 2016 Intouch Solutions, a leading marketing agency ... trend regarding the evolution of digital sales aids ... deliver compelling sales presentations via tablets. After conducting ... 2015, Intouch uncovered that while most pharmaceutical representatives ... many are not using them effectively during physician ...
(Date:2/10/2016)... -- Until recently, the options for reducing the appearance of ... approved the non-invasive Coolsculpting treatment, which removes fat cells ... in 2010 for the abdomen and this approval was ... this add-on approval, the experts at Laser Therapy Health ... CoolMini, to address smaller areas of fat. ...
Breaking Medicine Technology: